A family consisting of five members has been deeply affected by an 18-month quest to identify a rare and life-altering medical condition in their youngest child.
Three-year-old Skyla Smith started experiencing persistent leg pain before turning two, causing her significant distress and leading her mother, Elaine-Maree Telfer, to seek answers from medical professionals. Despite numerous doctor visits, the diagnosis for Skyla’s condition, Juvenile Idiopathic Arthritis (JIA), was only confirmed in October 2025, after a prolonged period of uncertainty.
Elaine-Maree, residing in Portnockie in northeastern Scotland, expressed the challenges of witnessing her daughter in pain and the relief mixed with anxiety upon finally learning the cause. JIA, affecting 1 in 10,000 UK children and more common in girls, involves the immune system attacking the body’s joints, potentially causing lasting harm without proper treatment.
Skyla now receives weekly methotrexate injections, alongside other medications, to manage her condition. While these injections alleviate some pain, Skyla’s routine includes regular medical appointments and blood tests, impacting her daily life and activities.
Despite the difficulties, Skyla’s family remains steadfast in ensuring she enjoys a fulfilling childhood. Supported by Juvenile Arthritis Research, Elaine-Maree aims to raise awareness about JIA, emphasizing the importance of early detection to prevent delays in treatment.
Elaine-Maree hopes that sharing Skyla’s journey will alert other parents to similar symptoms in their children. She advises parents to document and record instances of pain to aid in diagnosis and urges greater awareness of juvenile arthritis to prevent misconceptions about the condition.
